Biswajit Chakrabarti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Biswajit Chakrabarti has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Dan Wotton
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
3 shared publicationsElizabeth Kanwar
Advancing Quality Alliance, Salford, UK
3 shared publicationsJoanne Higgins
Advancing Quality Alliance, Salford, UK
3 shared publicationsTom Jenks
Advancing Quality Alliance, Salford, UK
3 shared publicationsChristopher J. Warburton
Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
2 shared publicationsE. McKnight
LungHealth Ltd, Swaffham, UK
2 shared publications
Latest Publications
- Open Access
- 3 July 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
The feasibility of implementing clinical decision support system software in the outpatient assessment of breathlessness: Cardio-LungHealth and Everton in the Community
Breathlessness is a common presentation to primary care yet one where a delay in appropriate investigation and diagnosis may result in adverse patient outcomes [1, 2]. The NHS England Adult Breathlessness Pathway facilitates a structured approach to the evaluation of breathlessness [3]. The common conditions responsible for breathlessness appear to disproportionately affect those most at risk from healthcare inequality [4, 5].
- 3 July 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (6)
Open AccessThe feasibility of implementing clinical decision support system software in the outpatient assessment of breathlessness: Cardio-LungHealth and Everton in the Community
Breathlessness is a common presentation to primary care yet one where a delay in appropriate investigation and diagnosis may result in adverse patient outcomes [1, 2]. The NHS England Adult Breathlessness Pathway facilitates a structured approach to the evaluation of breathlessness [3]. The common conditions responsible for breathlessness appear to disproportionately affect those most at risk from healthcare inequality [4, 5].
- Open Access
- 11 March 2025
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 35 (1) , 12
A service evaluation following the implementation of computer guided consultation software to support primary care reviews for chronic obstructive pulmonary disease
This study evaluates the impact of using a Clinical Decision Support System software in the form of a computer-guided consultation (CGC) when conducting Chronic Obstructive Pulmonary Disease (COPD) reviews in primary care. 5221 patients on the COPD register underwent CGC review with 21.1% found not to have COPD. Previously unrecognised cardiac disease was highlighted by the CGC in 7% of confirmed COPD cases. CGC review resulted in the number of patients possessing a self-management plan rising from 62-85%. 13% were found to have sub-optimal inhaler technique during CGC review with the CGC prompting correction in all cases. Only 26% of patients identified by the CGC as appropriate for Pulmonary Rehabilitation (PR) referral had previously attended a PR program. The integration of technology in the form of clinical decision support system software results in greater implementation of guideline-level care representing a scalable solution when performing COPD reviews.
- 11 March 2025
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 35 (1) , 12
Open AccessA service evaluation following the implementation of computer guided consultation software to support primary care reviews for chronic obstructive pulmonary disease
This study evaluates the impact of using a Clinical Decision Support System software in the form of a computer-guided consultation (CGC) when conducting Chronic Obstructive Pulmonary Disease (COPD) reviews in primary care. 5221 patients on the COPD register underwent CGC review with 21.1% found not to have COPD. Previously unrecognised cardiac disease was highlighted by the CGC in 7% of confirmed COPD cases. CGC review resulted in the number of patients possessing a self-management plan rising from 62-85%. 13% were found to have sub-optimal inhaler technique during CGC review with the CGC prompting correction in all cases. Only 26% of patients identified by the CGC as appropriate for Pulmonary Rehabilitation (PR) referral had previously attended a PR program. The integration of technology in the form of clinical decision support system software results in greater implementation of guideline-level care representing a scalable solution when performing COPD reviews.
- Open Access
- 7 February 2023
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 33 (1) , 1-7
The feasibility and impact of implementing a computer-guided consultation to target health inequality in Asthma
Greater Manchester has a greater prevalence and worse asthma outcomes than the national average. This study aims to evaluate a digital approach to primary care asthma management and in particular the initial impact of implementing Clinical Decision Support System software in the form of a computer-guided consultation (CGC) in the setting of primary care asthma reviews in deprived areas of Greater Manchester. The CGC (LungHealth Ltd) is an intelligent decision support system ensuring accurate guideline-based staging of asthma and assessment of asthma control with the software subsequently prompting guideline-standard management. Patients on asthma registers in Greater Manchester Primary Care Networks were identified and underwent remote review by nursing staff using the CGC linked directly to the GP clinical system. Three-hundred thirty-eight patients (mean age 59 (SD 17) years; 60% Female) were reviewed. The CGC reported the patient’s asthma control to be “Good” in 22%, “Partial” in 6% and “Poor” in 72%. ACT scores were significantly higher in those patients exhibiting “Good” and “Partial” control when compared to those with “Poor” control. The number of steroid courses and hospital admissions in the previous 12 months was significantly lower in those patients exhibiting “Good” and “Partial” control when compared to those with “Poor” control. Nineteen percent were found not to have a personalised asthma management plan during CGC review, which was alerted by the CGC and subsequently, all but 3 patients had this created on review completion (McNemar’s test; p < 0.001). 5% were found not to have been prescribed regular inhaled steroid therapy resulting in the operator being alerted by the CGC in all cases. Overall, 44% underwent alteration in asthma therapy following the CGC review with 82% of these representing treatment escalation. An end-to-end digital service solution is feasible for Asthma within primary care and the utilisation of a CGC when conducting primary care asthma reviews increases implementation of guideline-level management thus addressing healthcare inequality while enabling identification of “high risk” asthma patients and guiding appropriate therapy escalation and de-escalation.
- 7 February 2023
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 33 (1) , 1-7
Open AccessThe feasibility and impact of implementing a computer-guided consultation to target health inequality in Asthma
Greater Manchester has a greater prevalence and worse asthma outcomes than the national average. This study aims to evaluate a digital approach to primary care asthma management and in particular the initial impact of implementing Clinical Decision Support System software in the form of a computer-guided consultation (CGC) in the setting of primary care asthma reviews in deprived areas of Greater Manchester. The CGC (LungHealth Ltd) is an intelligent decision support system ensuring accurate guideline-based staging of asthma and assessment of asthma control with the software subsequently prompting guideline-standard management. Patients on asthma registers in Greater Manchester Primary Care Networks were identified and underwent remote review by nursing staff using the CGC linked directly to the GP clinical system. Three-hundred thirty-eight patients (mean age 59 (SD 17) years; 60% Female) were reviewed. The CGC reported the patient’s asthma control to be “Good” in 22%, “Partial” in 6% and “Poor” in 72%. ACT scores were significantly higher in those patients exhibiting “Good” and “Partial” control when compared to those with “Poor” control. The number of steroid courses and hospital admissions in the previous 12 months was significantly lower in those patients exhibiting “Good” and “Partial” control when compared to those with “Poor” control. Nineteen percent were found not to have a personalised asthma management plan during CGC review, which was alerted by the CGC and subsequently, all but 3 patients had this created on review completion (McNemar’s test; p < 0.001). 5% were found not to have been prescribed regular inhaled steroid therapy resulting in the operator being alerted by the CGC in all cases. Overall, 44% underwent alteration in asthma therapy following the CGC review with 82% of these representing treatment escalation. An end-to-end digital service solution is feasible for Asthma within primary care and the utilisation of a CGC when conducting primary care asthma reviews increases implementation of guideline-level management thus addressing healthcare inequality while enabling identification of “high risk” asthma patients and guiding appropriate therapy escalation and de-escalation.
- Open Access
- 29 March 2021
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1)
Correction: Ambient air pollution, lung function and COPD: cross-sectional analysis from the WHO Study of AGEing and adult health wave 1
- 29 March 2021
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1)
Open AccessCorrection: Ambient air pollution, lung function and COPD: cross-sectional analysis from the WHO Study of AGEing and adult health wave 1
- Open Access
- 29 March 2021
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1)
Correction: Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
- 29 March 2021
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1)
Open AccessCorrection: Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
- Open Access
- 26 March 2021
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1) , e000883
Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
Background There is a paucity of UK data to aid healthcare professionals in predicting which patients hospitalised with community-acquired pneumonia (CAP) are at greatest risk of 30-day readmission and to determine which readmissions may occur soonest. Methods An analysis of CAP cases admitted to nine UK hospitals participating in the Advancing Quality Pneumonia Programme. Results An analysis was performed of 12 157 subjects hospitalised with CAP in the Advancing Quality Programme Database. 26% of those discharged were readmitted within 30 days with readmission predicted by comorbidity including non-metastatic cancer, diabetes with complications and chronic kidney disease. 41% and 66% of readmissions occurred within 7 and 14 days of discharge, respectively. Patients readmitted within 14 days were more likely to have metastatic cancer (6.6% vs 4.5%; p=0.03) compared with those readmitted at 15–30 days. Conclusions A quarter of patients hospitalised for CAP are readmitted within 30 days; of those, two-thirds are readmitted within 2 weeks. Further research is required to determine whether such readmissions might be preventable through imple menting measures including in-hospital cross-specialty comorbidity management, convalescence in intermediate care, targeted rehabilitation and advanced care planning.
- 26 March 2021
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 8 (1) , e000883
Open AccessPredictors of 30-day readmission following hospitalisation with community-acquired pneumonia
Background There is a paucity of UK data to aid healthcare professionals in predicting which patients hospitalised with community-acquired pneumonia (CAP) are at greatest risk of 30-day readmission and to determine which readmissions may occur soonest. Methods An analysis of CAP cases admitted to nine UK hospitals participating in the Advancing Quality Pneumonia Programme. Results An analysis was performed of 12 157 subjects hospitalised with CAP in the Advancing Quality Programme Database. 26% of those discharged were readmitted within 30 days with readmission predicted by comorbidity including non-metastatic cancer, diabetes with complications and chronic kidney disease. 41% and 66% of readmissions occurred within 7 and 14 days of discharge, respectively. Patients readmitted within 14 days were more likely to have metastatic cancer (6.6% vs 4.5%; p=0.03) compared with those readmitted at 15–30 days. Conclusions A quarter of patients hospitalised for CAP are readmitted within 30 days; of those, two-thirds are readmitted within 2 weeks. Further research is required to determine whether such readmissions might be preventable through imple menting measures including in-hospital cross-specialty comorbidity management, convalescence in intermediate care, targeted rehabilitation and advanced care planning.
- Open Access
- 27 July 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 6 (3)
Implementation of a computer-guided consultation in the assessment of suspected obstructive sleep apnoea syndrome
Background: We describe implementation of a clinical decision support system, a computer-guided consultation (CGC), in the assessment of subjects referred with suspected obstructive sleep apnoea syndrome (OSAS).Methods: Two cohorts of patients were assessed. The first 100 cases had data collected with the CGC by a specialist sleep physician (stage1). A further 100 cases were assessed by a nonspecialist using the CGC (stage 2). For each case, the diagnosis suggested by the CGC was compared with the final diagnosis made by a second specialist sleep physician blinded to the CGC diagnosis.Results: Stage 1: of 100 people evaluated, a final diagnosis of OSAS was made by both the sleep specialist and CGC in 88% of cases. In 7 of the remaining 12 cases, both agreed there was “No evidence of OSAS”; in 5 cases the CGC did not reach a final diagnosis instead prompting specialist referral. Stage 2: 100 people were evaluated; 95% were evaluable. Both CGC and the sleep specialist made a diagnosis of OSAS in 83 cases (87%), in 5 cases both agreed there was no OSAS, whereas in 7 cases the CGC prompted a specialist review due to unexplained symptoms. The CGC was concordant with the final diagnosis in 95% and 93% of cases in the two cohorts, respectively and where there was doubt, prompted for clinical review. No OSAS cases were overlooked by the CGC.Conclusion: An intelligent CGC program creates opportunities in sleep medicine management pathways to safely yet effectively utilise nonspecialists working under specialist supervision.
- 27 July 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 6 (3)
Open AccessImplementation of a computer-guided consultation in the assessment of suspected obstructive sleep apnoea syndrome
Background: We describe implementation of a clinical decision support system, a computer-guided consultation (CGC), in the assessment of subjects referred with suspected obstructive sleep apnoea syndrome (OSAS).Methods: Two cohorts of patients were assessed. The first 100 cases had data collected with the CGC by a specialist sleep physician (stage1). A further 100 cases were assessed by a nonspecialist using the CGC (stage 2). For each case, the diagnosis suggested by the CGC was compared with the final diagnosis made by a second specialist sleep physician blinded to the CGC diagnosis.Results: Stage 1: of 100 people evaluated, a final diagnosis of OSAS was made by both the sleep specialist and CGC in 88% of cases. In 7 of the remaining 12 cases, both agreed there was “No evidence of OSAS”; in 5 cases the CGC did not reach a final diagnosis instead prompting specialist referral. Stage 2: 100 people were evaluated; 95% were evaluable. Both CGC and the sleep specialist made a diagnosis of OSAS in 83 cases (87%), in 5 cases both agreed there was no OSAS, whereas in 7 cases the CGC prompted a specialist review due to unexplained symptoms. The CGC was concordant with the final diagnosis in 95% and 93% of cases in the two cohorts, respectively and where there was doubt, prompted for clinical review. No OSAS cases were overlooked by the CGC.Conclusion: An intelligent CGC program creates opportunities in sleep medicine management pathways to safely yet effectively utilise nonspecialists working under specialist supervision.
- 15 October 2019
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (8) , 1063-1065
Detection of Expiratory Flow Limitation by Forced Oscillations during Noninvasive Ventilation
- 15 October 2019
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (8) , 1063-1065
Detection of Expiratory Flow Limitation by Forced Oscillations during Noninvasive Ventilation
- Open Access
- 25 March 2018
- Published by Springer Nature in Pneumonia
- Vol. 10 (1) , 2
The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study
The majority of patients with community acquired-pneumonia (CAP) are treated in primary care and the mortality in this group is very low. However, a small but significant proportion of patients who begin treatment in the community subsequently require admission due to symptomatic deterioration. This study compared patients who received community antibiotics prior to admission to those who had not, and looked for associations with clinical outcomes. This study analysed the Advancing Quality (AQ) Pneumonia database of patients admitted with CAP to 9 acute hospitals in the northwest of England over a 12-month period. There were 6348 subjects (mean age 72 [SD 16] years; gender ratio 1:1) admitted with CAP, of whom 17% had been pre-treated with antibiotics. The in-hospital mortality was 18.6% for the pre-treatment group compared to 13.2% in the “antibiotic naïve” group (p < 0.001). On multivariate analysis, age, male gender and antibiotic pre-treatment were predictors of in-hospital mortality along with a history of cerebrovascular accident, congestive cardiac failure, dementia, renal disease and cancer. After adjustment for CURB-65 score, age, co-morbidities and pre-treatment with antibiotics remained as independent risk factors for in-hospital mortality (OR 1.43, 95% CI 1.19–1.71). CAP patients admitted to hospital were more likely to die during admission if they had received antibiotics for the same illness pre-admission. Future studies should endeavor to determine the mechanisms underlying this association, such as microbiological factors and the role of comorbidities. Patients hospitalized with CAP despite prior antibiotic treatment in the community require close monitoring.
- 25 March 2018
- Published by Springer Nature in Pneumonia
- Vol. 10 (1) , 2
Open AccessThe association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study
The majority of patients with community acquired-pneumonia (CAP) are treated in primary care and the mortality in this group is very low. However, a small but significant proportion of patients who begin treatment in the community subsequently require admission due to symptomatic deterioration. This study compared patients who received community antibiotics prior to admission to those who had not, and looked for associations with clinical outcomes. This study analysed the Advancing Quality (AQ) Pneumonia database of patients admitted with CAP to 9 acute hospitals in the northwest of England over a 12-month period. There were 6348 subjects (mean age 72 [SD 16] years; gender ratio 1:1) admitted with CAP, of whom 17% had been pre-treated with antibiotics. The in-hospital mortality was 18.6% for the pre-treatment group compared to 13.2% in the “antibiotic naïve” group (p < 0.001). On multivariate analysis, age, male gender and antibiotic pre-treatment were predictors of in-hospital mortality along with a history of cerebrovascular accident, congestive cardiac failure, dementia, renal disease and cancer. After adjustment for CURB-65 score, age, co-morbidities and pre-treatment with antibiotics remained as independent risk factors for in-hospital mortality (OR 1.43, 95% CI 1.19–1.71). CAP patients admitted to hospital were more likely to die during admission if they had received antibiotics for the same illness pre-admission. Future studies should endeavor to determine the mechanisms underlying this association, such as microbiological factors and the role of comorbidities. Patients hospitalized with CAP despite prior antibiotic treatment in the community require close monitoring.
- 1 January 2017
- Published by Elsevier in Respiratory Medicine
- Vol. 122, 18-22
Pulse transit time changes in subjects exhibiting sleep disordered breathing
- 1 January 2017
- Published by Elsevier in Respiratory Medicine
- Vol. 122, 18-22
Pulse transit time changes in subjects exhibiting sleep disordered breathing